Lalit Kumar
Director - Clinical Bioanalytics & Translational Science Beam Therapeutics
Lalit Kumar is a Senior Director at Beam Therapeutics, specializing in translational pharmacology across hematology and immuno-oncology. An innovative immunologist, he has experience spanning drug discovery through clinical development, including CTA/IND-enabling activities. He has led biomarker strategies to support indication selection, patient enrichment, and combination approaches. Dr. Kumar is experienced in building cross-functional collaborations across academia, industry, and CROs, and is familiar with regulatory guidance from the U.S. Food and Drug Administration and European Medicines Agency. He is also an inventor in allogeneic CAR-T cell detection strategies.
Seminars
- Examining how immune responses to vectors and cargo drive blood clearance of gene editing therapies to help you identify strategies that improve therapeutic persistence
- Exploring approaches to reduce immune-mediated clearance during repeat dosing to equip you with practical solutions for maintaining therapeutic efficacy over time
- Assessing how leading companies are engineering vectors to evade immune recognition to give you real-world insights into overcoming immunogenicity in your program
